Xpresspa group, inc. (XSPA)

CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Sep'11
Cash flows from operating activities
Consolidated net loss

-20,530

-20,056

-18,487

-15,740

-36,746

-40,847

-42,326

-45,890

-28,389

-21,783

-22,500

-26,397

-24,003

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Consolidated net loss from discontinued operations

-

0

0

-510

-1,115

-8,918

-9,617

-11,404

-12,277

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-20,530

-20,056

-18,487

-15,230

-35,631

-31,929

-32,709

-34,486

-16,112

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-52,503

-50,687

-51,578

-52,433

-47,469

-40,033

-30,934

-20,841

-8,163

0

0

0

Adjustments to reconcile consolidated net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization

6,124

6,715

7,130

7,394

7,398

6,972

6,815

7,903

7,976

6,292

4,752

2,192

1,317

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-356

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Change in deferred tax assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-58

-58

-162

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,185

3,722

3,907

4,023

5,859

4,792

5,080

5,220

5,146

4,755

3,626

2,501

1,381

0

0

0

Amortization of debt discount and debt issuance costs

1,031

1,352

1,662

1,380

986

0

0

0

-

-

-

-

1,871

2,118

2,509

2,573

2,159

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

335

417

576

708

916

1,190

1,275

1,748

2,177

2,753

2,959

2,726

2,448

2,320

2,901

3,655

5,064

6,595

8,274

10,039

10,967

11,681

11,795

11,799

12,093

11,530

14,034

11,097

8,087

5,905

0

0

0

Amendment to warrants as part of debt modification

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of shares for extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of shares of Common Stock for services

-

-

-

-

-

-

-

-

27

1,841

1,894

1,885

65

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of Common Stock for payment of interest

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of goodwill and investment

-

0

0

0

19,630

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on disposal of assets

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative warrant liabilities

-

-

0

0

-

-

0

0

-

-

-

-173

-158

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent liability assumed from acquisition

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on the sale of patents

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants and conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

Assignment of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

0

0

0

-

-

-

-

-

Change in fair value of derivative warrant liabilities and conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,081

-58

-1,896

-1,196

-1,613

4,981

6,471

6,847

7,240

0

0

0

Exchange rate loss, net

-

-

-

-

-

-

-

-

-

-

-

-

89

91

-84

-34

-346

-556

-414

-398

-192

111

136

81

97

0

0

0

-

-

-

-

0

Changes in assets and liabilities:
Increase in accounts receivable, net

-

-

-

-

-

-

-

-

-

-

-

-

-

1,581

139

814

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

(Increase) decrease in inventory

-

0

0

-169

-

-737

-1,186

-1,237

-1,347

-1,130

-339

-389

-74

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in other current assets and other assets

-

-

-

-60

-

-

-

2,616

636

-1,206

-745

-466

-284

0

0

0

-

-

-

-

-374

294

-23

105

135

-13

142

85

208

519

0

0

0

Decrease (increase) in other current assets and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in accounts payable, accrued expenses and other current liabilities

3,760

118

325

235

-604

-20

-679

-954

-3,114

-8,571

-6,307

-2,726

-2,880

-3,343

-1,793

-2,343

378

3,288

4,052

3,554

763

3,836

1,383

-1,250

3,538

364

826

1,817

7

2,588

0

0

0

Increase (decrease) in deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other liabilities

-

50

-235

-116

-55

-1,264

-1,166

-475

-368

778

754

123

-280

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities - continuing operations

-113

-2,720

-2,762

-4,186

-8,067

-9,647

-10,695

-10,637

-8,761

-5,425

-7,035

179

-3,429

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities - discontinued operations

-

0

40

138

1,501

3,806

2,683

1,030

-3,411

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-113

-2,720

-2,722

-4,048

-6,566

-5,841

-8,012

-9,607

-12,172

0

0

0

-

-

-

-

-

-

-

-23,391

-28,382

-26,296

-25,454

-27,086

-23,465

-25,890

-22,804

-18,113

-14,468

-6,216

0

0

0

Cash flows from investing activities:
Increase in deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash acquired as part of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

2,114

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,326

3,326

0

0

0

0

Acquisition of property and equipment

2,275

1,990

1,775

2,428

3,031

5,191

5,236

4,849

4,479

1,793

1,216

874

66

0

0

0

-

-

-

-

246

242

137

67

23

84

228

231

208

156

0

0

0

Acquisition of software

-

-58

8

19

85

45

239

299

233

331

71

-86

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

22,548

22,548

0

0

0

0

Proceeds from the sale of patents

-

0

0

0

250

250

400

400

150

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of software

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in deposits

-

-

-

-

-

-

-

-

-

-

-

-

-2,001

-2,025

-2,040

-1,203

248

372

387

2,682

2,404

0

0

0

-

-

-

-

-

-

-

-

-

Net cash used in investing activities - continuing operations

-

-

0

-2,247

-

-

-3,999

-3,672

-4,286

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received from payment of note receivable

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities - discontinued operations

-

-

0

0

-

-

-702

-985

-1,110

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

Increase in deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

193

-8

38

38

46

0

0

0

-

Net cash used in investing activities

-2,275

-1,732

-1,583

-2,247

-1,866

-4,282

-4,701

-4,657

-5,396

0

0

0

-

-

-

-

-

-

-

-2,856

-2,650

-3,494

-942

1,432

-1,636

-749

-22,608

-22,611

-19,476

-22,819

0

0

0

Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance cost of $52

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

Proceeds from issuance of common stock, net of issuance cost of $39

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

Proceeds from issuance (repayment) of note payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

Proceeds from issuance of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

Financing round net of issuance cost of $52

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the issuance of note to Calm

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,160

2,161

2,981

2,496

974

1,311

662

518

509

0

0

0

0

Exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,292

11,316

11,708

1,690

590

11,243

12,449

12,440

12,275

0

0

0

0

Debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

50

50

50

268

218

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net proceeds from sale and issuance of shares of Common Stock in public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76,110

76,110

2,360

0

0

0

Repayment of debt and line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Distributions to noncontrolling interests

1,197

894

836

1,582

1,636

1,471

1,461

672

452

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities - continuing operations

-

-

0

5,698

-

-

9,325

6,228

6,448

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities - discontinued operations

-

-

0

0

-

-

0

0

-361

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,165

4,404

2,214

5,698

5,644

2,722

9,325

6,228

6,087

0

0

0

-

-

-

-

-

-

-

10,656

13,452

13,477

14,689

4,186

1,564

57,516

86,021

85,868

85,694

37,077

0

0

0

Effect of exchange rate changes

-32

-81

-166

-132

-177

-146

-112

-83

-61

-133

-164

-58

-13

9

9

11

6

-3

-6

12

17

167

173

158

163

10

8

4

-2

1

0

0

0

Decrease in cash and cash equivalents and restricted cash

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-11,542

-11,607

-19,491

-8,887

-7,041

7,277

7,222

8,321

8,928

-9,888

-11,427

-15,579

-17,563

-16,146

-11,534

-21,310

-23,374

30,887

40,617

45,148

51,748

8,043

0

0

0

Interest

735

779

641

764

731

731

889

731

731

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

-

9

0

0

0

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

19

10

10

7

0

0

0

0

Non-cash investing and financing transactions
Non-cash acquisition of cost method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

787

0

0

0

-

-

-

-

-

-

-

-

-

Conversion of senior notes and warrants into Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,707

0

0

0

-

-

-

-

-

-

-

-

-

Working capital (excluding cash and cash equivalents)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Line of credit with interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of Series F Convertible Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of derivative warrants into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

175

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

Change in classification of derivative warrant liabilities into equity warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

Issuance of shares of Common Stock to pay debt and interest

-

-

-

0

-

-

-

0

-

-

-

-

2,996

3,875

10,986

12,387

9,391

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of contingent liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash acquired as part of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

2,114

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,326

3,326

0

0

0

0

Non-cash acquisition of cost method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Conversion of Series A preferred stock to common stock shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Stock subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Exercise of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Non-cash acquisition of patents through issuance of common stock (Note 6)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

750

750

0

0

0

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, prior to the Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

76

0

0

0

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, upon the Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, upon Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, upon Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Conversion of Series A Convertible Preferred stock, classified as equity, into common stock, after the Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

201

201

0

0

0

0